Epigenetic regulation of gene expression by the exoribonuclease pacman
Epigenetic regulation of gene expression by the exoribonuclease pacman
批准号:
BB/I021345/1
负责人:
Sarah Newbury
金额:
$56.98万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development of an organism from egg to adult requires sets of genes to be switched on and off at particular times and in the correct order. If genes are not switched off when necessary, cells can continue to multiply in an uncontrolled way leading to cancer. As well as being important in cancer, gene regulation is crucial in controlling the balance between stem cell self-renewal and pathways to cell specialisation which are required to form the particular cells and tissues in the body. Since stem cells have a vast potential in regenerative medicine for the replacement of defective tissue, the understanding of gene control is crucial for harnessing the potential of these cells. Therefore studying the mechanisms whereby genes are switched off (as well as on) is vitally important for providing basic knowledge that has potential to lead to novel therapeutics. Using the fruit fly Drosophila as a model organism, we have recently discovered that an enzyme named Pacman is involved in the growth and differentiation of imaginal discs, which form adult structures such as wings and legs. Imaginal discs are similar to stem cells in that they carry the information to build the adult tissue. We have shown that Pacman normally affects the production of a protein called Simjang (Korean for 'strong heart') which in turn controls a gene silencing complex (the NuRD complex) which shuts down parts of the chromosome, preventing genes from being turned on. This gene silencing complex is important because it is known to be involved in many critical cellular events including tissue regeneration, formation of blood cells, ageing and spread of cancer cells. This is the first time that an enzyme involved in degradation of messenger RNA has been shown to be directly affecting a gene silencing complex. The aim of this project is to understand how the Pacman uses Simjang to control particular sets of genes involved in growth and differentiation. Our hypothesis is that, in normal cells, simjang messenger RNA is somehow 'tagged' for destruction so that not much of Simjang protein is made. This means that there is not enough Simjang to turn on the gene silencing complexes. These gene silencing complexes, when activated, normally act as 'brakes' to prevent growth and differentiation of the wing disc. Therefore when the brake is not pressed by Simjang, these genes are not turned on, allowing normal growth and development of the tissue. When the pacman gene is mutated, there is no (or little) degradation of simjang RNA, resulting in more Simjang protein, which turns on the gene silencing complexes (i.e. presses the brake) therefore switching on genes that prevent tissue growth and development. In this project we aim to test this hypothesis, find out the details of this gene control pathway and identify the genes which act as brakes to prevent growth and development. The mechanism of gene regulation which forms the basis of this proposal is entirely novel; as yet no research group has found this link between RNA degradation and gene silencing. Since all the proteins involved are similar in Drosophila and humans the new 'control module' we have discovered is likely to be relevant to gene regulation in humans. Since Pacman is known to be important in other important cellular events such as wound healing, migration of cell sheets, and male fertility, this work may also shed light on the molecular mechanisms of these processes in other tissues. Therefore the insights we gain during this project may help us to improve treatment for cancer and other diseases and also help us to understand the ways that tissues grow and develop. This project will therefore provide valuable insights into a new method of gene regulation which can be used in the development of new therapeutics.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/bjc.2012.525
发表时间:
2012-12-04
期刊:
BRITISH JOURNAL OF CANCER
影响因子:
8.8
作者:
[Jones, C. I., Zabolotskaya, M. V., King, A. J., Stewart, H. J. S., Horne, G. A., Chevassut, T. J., Newbury, S. F.]
通讯作者:
Newbury, S. F.
XRN 5'→3' exoribonucleases: structure, mechanisms and functions.
XRN 5'→3'驱虫核酸酶:结构,机制和功能。
DOI:
10.1016/j.bbagrm.2013.03.005
发表时间:
2013-06
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子:
4.7
作者:
[Nagarajan, Vinay K., Jones, Christopher I., Newbury, Sarah F., Green, Pamela J.]
通讯作者:
Green, Pamela J.
DOI:
10.1093/nar/gkv1336
发表时间:
2016-01-08
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Jones CI, Pashler AL, Towler BP, Robinson SR, Newbury SF]
通讯作者:
Newbury SF
DOI:
10.1038/srep28006
发表时间:
2016-06-20
期刊:
Scientific reports
影响因子:
4.6
作者:
[Caserta S, Kern F, Cohen J, Drage S, Newbury SF, Llewelyn MJ]
通讯作者:
Llewelyn MJ
DOI:
10.3389/fimmu.2017.01977
发表时间:
2017
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Caserta S, Mengozzi M, Kern F, Newbury SF, Ghezzi P, Llewelyn MJ]
通讯作者:
Llewelyn MJ
共 6 条
Unlocking the molecular and cellular mechanisms regulated by the ribonuclease Dis3L2 in Drosophila and human cell proliferation.
-
批准号:BB/V001701/1
-
项目类别:Research Grant
-
资助金额:$60.49万
-
财政年份:2021
-
负责人:Sarah Newbury
-
依托单位:
Understanding the cellular pathways regulated by Dis3L2 in cell proliferation.
-
批准号:BB/P021042/1
-
项目类别:Research Grant
-
资助金额:$54.57万
-
财政年份:2018
-
负责人:Sarah Newbury
-
依托单位:
Targeted mRNA degradation in Drosophila spermatogenesis
-
批准号:BB/I007989/1
-
项目类别:Research Grant
-
资助金额:$55.21万
-
财政年份:2011
-
负责人:Sarah Newbury
-
依托单位:
Function of the exoribonuclease pacman in cell movement and cell shape change
-
批准号:BB/G002754/1
-
项目类别:Research Grant
-
资助金额:$53.28万
-
财政年份:2008
-
负责人:Sarah Newbury
-
依托单位:
Analysis of the role of ribonucleases in the regulation of epithelial sheet sealing
-
批准号:BB/C005163/2
-
项目类别:Research Grant
-
资助金额:$19.34万
-
财政年份:2007
-
负责人:Sarah Newbury
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: